Is CbdMD Stock a Good Investment?

CbdMD Investment Advice

YCBD

To provide specific investment advice or recommendations on cbdMD Inc stock, we recommend investors consider the following general factors when evaluating cbdMD Inc. This will help you to make an informed decision on whether to include CbdMD in one of your diversified portfolios:

Examine CbdMD's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research CbdMD's leadership team and their track record. Good management can help CbdMD navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact CbdMD's business and its evolving consumer preferences.
Compare CbdMD's performance and market position to its competitors. Analyze how CbdMD is positioned in terms of product offerings, innovation, and market share.
Check if CbdMD pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about CbdMD's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in cbdMD Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if cbdMD Inc is a good investment.

Sell

Buy

Strong Sell

We provide trade advice to complement the prevailing expert consensus on cbdMD Inc. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure CbdMD is not overpriced, please confirm all cbdMD Inc fundamentals, including its shares owned by institutions, gross profit, debt to equity, as well as the relationship between the price to book and cash and equivalents . As cbdMD Inc appears to be a penny stock we also recommend to validate its number of shares shorted numbers.

Market Performance	Very Weak	Details
Volatility	Extremely Dangerous	Details
Hype Condition	Stale	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Very High	Details
Economic Sensitivity	Moves totally opposite to the market	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Buy	Details
Financial Strenth (F Score)	Poor	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine CbdMD Stock

Researching CbdMD's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 19.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.57. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. cbdMD Inc recorded a loss per share of 10.9. The entity had not issued any dividends in recent years. The firm had 1:45 split on the 25th of April 2023.

To determine if CbdMD is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CbdMD's research are outlined below:

	cbdMD Inc generated a negative expected return over the last 90 days
	cbdMD Inc has some characteristics of a very speculative penny stock
	cbdMD Inc has high historical volatility and very poor performance
	cbdMD Inc has a very high chance of going through financial distress in the upcoming years
	The company reported the previous year's revenue of 24.16 M. Net Loss for the year was (22.94 M) with profit before overhead, payroll, taxes, and interest of 22.34 M.
	cbdMD Inc currently holds about 10.55 M in cash with (4.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
	cbdMD Inc has a poor financial position based on the latest SEC disclosures
	Roughly 19.0% of the company outstanding shares are owned by insiders
	Latest headline from news.google.com: cbdMD Launches THC Seltzers in 4B Market Push with Fast-Acting Technology YCBD Stock News - StockTitan

CbdMD Quarterly Liabilities And Stockholders Equity

13.84 Million

CbdMD uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in cbdMD Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CbdMD's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	12th of February 2024 Upcoming Quarterly Report	View
	31st of December 2023 Next Fiscal Quarter End	View

Earnings surprises can significantly impact CbdMD's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises CbdMD's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2023-08-10	2023-06-30	-0.04	-0.03	0.01	25
2023-05-15	2023-03-31	-0.04	-0.03	0.01	25
2023-02-13	2022-12-31	-0.04	-0.03	0.01	25
2022-02-10	2021-12-31	-0.04	-0.03	0.01	25
2021-12-17	2021-09-30	-0.04	-0.07	-0.03	75
2021-08-12	2021-06-30	-0.04	-0.01	0.03	75
2019-05-15	2019-03-31	-0.05	-0.09	-0.04	80
2024-05-15	2024-03-31	-0.75	-0.87	-0.12	16

CbdMD's market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.73 M.

Market Cap

2.28 Million

CbdMD's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(2.03)	(2.13)
Return On Capital Employed	(0.92)	(0.88)
Return On Assets	(1.63)	(1.71)
Return On Equity	(2.29)	(2.40)

The company has Profit Margin (PM) of (0.94) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

Determining CbdMD's profitability involves analyzing its financial statements and using various financial metrics to determine if CbdMD is a good buy. For example, gross profit margin measures CbdMD's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CbdMD's profitability and make more informed investment decisions.

Please note, the presentation of CbdMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CbdMD's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CbdMD's management manipulating its earnings.

Evaluate CbdMD's management efficiency

cbdMD Inc has return on total asset (ROA) of (0.1571) % which means that it has lost $0.1571 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3507) %, meaning that it created substantial loss on money invested by shareholders. CbdMD's management efficiency ratios could be used to measure how well CbdMD manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -2.13. The current year's Return On Capital Employed is expected to grow to -0.88. At present, CbdMD's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 167.5 K, whereas Non Current Assets Total are forecasted to decline to about 8.9 M.

	Last Reported	Projected for Next Year
Book Value Per Share	4.02	3.82
Tangible Book Value Per Share	2.59	2.72
Enterprise Value Over EBITDA	(0.48)	(0.50)
Price Book Value Ratio	0.27	0.25
Enterprise Value Multiple	(0.48)	(0.50)
Price Fair Value	0.27	0.25
Enterprise Value	4.6 M	4.3 M

CbdMD's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.

Beta

1.991

Basic technical analysis of CbdMD Stock

As of the 26th of November, CbdMD shows the Risk Adjusted Performance of (0.02), mean deviation of 3.18, and Coefficient Of Variation of (2,756). In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of CbdMD, as well as the relationship between them. Please confirm cbdMD Inc standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and potential upside to decide if cbdMD Inc is priced correctly, providing market reflects its regular price of 0.47 per share. As cbdMD Inc is a penny stock we also strongly suggest to validate its jensen alpha numbers.

CbdMD's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CbdMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on CbdMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CbdMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Kennedy Thomas Ronan over a month ago Acquisition by Kennedy Thomas Ronan of 16667 shares of CbdMD subject to Rule 16b-3
		Kennedy Thomas Ronan over two months ago Acquisition by Kennedy Thomas Ronan of 1000 shares of CbdMD at 270.0 subject to Rule 16b-3
		Kennedy Thomas Ronan over two months ago Acquisition by Kennedy Thomas Ronan of 38465 shares of CbdMD at 270.0 subject to Rule 16b-3
		Raines William F Iii over three months ago Acquisition by Raines William F Iii of 75000 shares of CbdMD subject to Rule 16b-3
		Bradley Whitford over six months ago Disposition of tradable shares by Bradley Whitford of CbdMD subject to Rule 16b-3
		Sellers Bakari T. over six months ago Acquisition by Sellers Bakari T. of 2000 shares of CbdMD at 0.93 subject to Rule 16b-3
		Wiesehan John J Iii over six months ago Acquisition by Wiesehan John J Iii of 161550 shares of CbdMD at 2000000.0 subject to Rule 16b-3
		Sellers Bakari T over a year ago Acquisition by Sellers Bakari T of 5000 shares of CbdMD subject to Rule 16b-3

CbdMD's Outstanding Corporate Bonds

CbdMD issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. cbdMD Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CbdMD bonds can be classified according to their maturity, which is the date when cbdMD Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	CHTR 6375 01 SEP 29 Corp Bond US1248EPCS01	View
	CHTR 7375 01 MAR 31 Corp Bond US1248EPCT83	View
	US1248EPCN14 Corp Bond US1248EPCN14	View
	US1248EPCP61 Corp Bond US1248EPCP61	View
	US1248EPCQ45 Corp Bond US1248EPCQ45	View
	CCO HLDGS LLC Corp Bond US1248EPCK74	View

View All CbdMD Corporate Bonds

Understand CbdMD's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing CbdMD's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	(0.02)
	Market Risk Adjusted Performance	0.1905
	Mean Deviation	3.18
	Coefficient Of Variation	(2,756)
	Standard Deviation	4.62
	Variance	21.36
	Information Ratio	(0.06)
	Jensen Alpha	(0.06)
	Total Risk Alpha	(0.91)
	Treynor Ratio	0.1805
	Maximum Drawdown	28.6
	Value At Risk	(7.41)
	Potential Upside	6.38
	Skewness	1.05
	Kurtosis	4.14

	Risk Adjusted Performance	(0.02)
	Market Risk Adjusted Performance	0.1905
	Mean Deviation	3.18
	Coefficient Of Variation	(2,756)
	Standard Deviation	4.62
	Variance	21.36
	Information Ratio	(0.06)
	Jensen Alpha	(0.06)
	Total Risk Alpha	(0.91)
	Treynor Ratio	0.1805
	Maximum Drawdown	28.6
	Value At Risk	(7.41)
	Potential Upside	6.38
	Skewness	1.05
	Kurtosis	4.14

Consider CbdMD's intraday indicators

CbdMD intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CbdMD stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	4223.35
	Daily Balance Of Power	0.25
	Rate Of Daily Change	1.02
	Day Median Price	0.47
	Day Typical Price	0.47
	Price Action Indicator	0.005
	Period Momentum Indicator	0.01
	Relative Strength Index	42.25

CbdMD time-series forecasting models is one of many CbdMD's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CbdMD's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

CbdMD Stock media impact

Far too much social signal, news, headlines, and media speculation about CbdMD that are available to investors today. That information is available publicly through CbdMD media outlets and privately through word of mouth or via CbdMD internal channels. However, regardless of the origin, that massive amount of CbdMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of CbdMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CbdMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CbdMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CbdMD alpha.

CbdMD Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards CbdMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

CbdMD Corporate Management

Zeb Booker	Chief Officer	Profile
Raymond Coffman	CoFounder Chairman	Profile
Kevin MacDermott	President	Profile
John Weston	Director Relations	Profile
Shannon Charles	Chief Officer	Profile
Francisco Mangual	Senior Sales	Profile

Already Invested in cbdMD Inc?

The danger of trading cbdMD Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CbdMD is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CbdMD. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile cbdMD Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports: